Effect of Riboflavin Solution With Hydroxypropyl Methylcellulose and Eyelid Speculum on Pachymetry Changes During Accelerated Collagen Crosslinking

Cornea. 2019 Jul;38(7):864-867. doi: 10.1097/ICO.0000000000001938.

Abstract

Purpose: To assess corneal thickness changes with isotonic riboflavin (RF) solution with hydroxylpropyl methylcellulose in patients undergoing accelerated corneal collagen crosslinking (CXL) with and without an eyelid speculum.

Methods: Fifty-two eyes of 48 patients with progressive keratoconus were enrolled in this study. The patients in this study were divided into 2 groups: in group 1 an eyelid speculum was removed during 20-minute RF (0.1%) + hydroxylpropyl methylcellulose (Mediocross M; Avedro Inc, Waltham, MA) instillation, and in group 2 the eyelid speculum was retained in place during the entire CXL procedure. All patients underwent accelerated CXL using continuous ultraviolet-A (UVA) light exposure at 9 mW/cm for 10 minutes; total energy dose was 5.4 J/cm. Intraoperative ultrasound pachymetry measurements were obtained before and after epithelial removal, after RF loading, and after UVA light exposure at 5 and 10 minutes.

Results: The preoperative pachymetric measurements decreased in both groups after the removal of epithelium [group 1 (n = 26): -25 μm, group 2 (n = 26): -31 μm, P = 0.234]. Although the thinnest pachymetry significantly increased after soaking in both group 1 (52.26 μm) and group 2 (27.88 μm, P < 0.001), closure of the eyelids during RF instillation further increased the pachymetry readings (P < 0.0001). The corneal thickness remained stable in both groups during UVA irradiation at 5 and 10 minutes (P > 0.05).

Conclusions: Closure of the eyelids further induces corneal swelling that may offer an advantage to improve safety of the procedure particularly in thin corneas.

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Collagen / metabolism*
  • Cornea / drug effects*
  • Cross-Linking Reagents / therapeutic use
  • Female
  • Humans
  • Hypromellose Derivatives / pharmacology
  • Hypromellose Derivatives / therapeutic use*
  • Keratoconus / drug therapy*
  • Male
  • Photochemotherapy / instrumentation
  • Photochemotherapy / methods*
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use*
  • Riboflavin / pharmacology
  • Riboflavin / therapeutic use*
  • Surgical Instruments
  • Ultraviolet Rays
  • Young Adult

Substances

  • Cross-Linking Reagents
  • Photosensitizing Agents
  • Hypromellose Derivatives
  • Collagen
  • Riboflavin